In CT26 the predominant isoform expressed by infiltrating immune cells is TGFβ1 (Supplementary Fig. 6) and correspondingly anti-TGFβ1 demonstrated superior tumor control (Fig. 3d). This evidence concerns the gene TGFB1 and neoplasm.